Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Urovant
Urovant
Urovant's lead drug disappoints in mid-stage study as first big FDA decision looms
Urovant's lead drug disappoints in mid-stage study as first big FDA decision looms
Endpoints
Urovant
vibegron
IBS-d
clinical trials
Flag link:
As Urovant gears up for vibegron FDA decision, the biotech gets snapped up by Sumitovant Biopharma
As Urovant gears up for vibegron FDA decision, the biotech gets snapped up by Sumitovant Biopharma
Fierce Biotech
Urovant
Roivant
FDA
vibegron
overactive bladder
Flag link:
Vivek Ramaswamy’s Urovant claims a big win in PhIII — but questions linger about a cheap generic and their branded rival
Vivek Ramaswamy’s Urovant claims a big win in PhIII — but questions linger about a cheap generic and their branded rival
Endpoints
Axovant
Alzheimer's disease
Roivant
Vivek Ramaswamy
Urovant
vibegron
urinary incontinence
Flag link: